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Abstract
Introduction: Solid pseudopapillary tumor of the pancreas is extremely rare in children; it usually occurs in young
women between 18 and 35 years of age. It comprises less than 3 % of pancreatic tumors. It is of low malignancy;
however, it may be locally aggressive. Surgical resection is the treatment of choice and its prognosis is excellent.
Case presentation: Two Caucasian girls, 15 and 12 years of age were diagnosed with tumor of the pancreas. The first
patient had severe abdominal pain. In the second case the tumor was asymptomatic, detected incidentally during
ultrasound. Computed tomography confirmed pancreatic mass. In the first case, apart from the tumor located in the
head and the body of her pancreas, focal change in her right kidney was found, which was an indication to biopsy
that confirmed solid pseudopapillary tumor. In the second patient the tumor was located in the body of her pancreas,
with portal vein occlusion and well-developed collateral circulation. In the first patient a pancreatoduodenectomy
(Traverso-Longmire) was performed; there was no mass in her right kidney. In the second case, distal pancreatectomy
and splenectomy were performed. In both cases histopathology revealed solid pseudopapillary tumor resected
radically. Our first patient’s postoperative course was uneventful. In the second case, her postoperative course was
complicated by necrosis of the remaining pancreatic head that needed pancreatoduodenectomy. Follow-up at 28 and
26 months revealed no evidence of tumor recurrence or metastases on magnetic resonance imaging.
Conclusions: Typical radiological appearance of solid pseudopapillary tumor is an indication for surgery. The treatment
of choice is tumor resection with sparing of pancreatic tissue. In one of our two cases we performed a preoperative
biopsy because of an uncharacteristic mass in her right kidney. In our second patient, necrosis of her spared pancreatic
head meant that we could not preserve pancreatic tissue. Our whole diagnostic process, treatment and possible
complications analysis should be of interest and noteworthy not only to surgeons as the treatment of choice is radical
resection, but also to pediatric oncologists because of differentiation from other pancreatic tumors in children.
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Introduction
Solid pseudopapillary tumor of the pancreas (SPT,
Frantz’s tumor) is very rarely diagnosed in children. The
entity was first described in 1959 by pathologist Virginia
Kneeland Frantz and in 1996 reclassified by the World
Health Organization (WHO) [1–3]. It comprises only
0.2 to 2.7 % of all tumors of the pancreas. Up to 2014
there were approximately 900 well-documented cases of
pancreatic SPTs with only a small minority of them
concerning children [4–7]. It occurs predominantly in
young women between 18 and 35 years of age. The
clinical manifestation of this disease is usually a slowly
growing abdominal mass with or without abdominal
pain. It is of low malignant potential; however, some
cases may be locally aggressive and infiltrative, with me-
tastases to the liver, lung and skin [4]. The pathogenesis
is still unknown [8]. On histological examination the
tumor is a solid mass with pseudopapillary and pseudo-
cystic structures with rich microvasculature in various
proportions. Surgical resection is the treatment of
choice, and its prognosis is excellent, with 10-year
survival approaching 100 %.
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The aim of this study is to analyze symptoms, diagno-
sis, treatment and long-term outcomes of two adolescent
girls treated for SPT of the pancreas.
Case presentation
Case 1
A 15-year-old Caucasian girl was admitted to our de-
partment with severe epigastric pain over 2 days with a
temperature of 38 °C. In laboratory tests slightly elevated
white blood cells (WBC) level (12 × 103) and C-reactive
protein (5.3 mg/dl) were found. An ultrasound (USG)
examination and computed tomography (CT) scans
showed the presence of a tumor located in the head and
the trunk of her pancreas (4.8 × 4.2 × 5 cm3; Fig. 1).
Another mass (approximately 2 cm in diameter) was
detected in the upper pole of her right kidney (Fig. 2).
The tumor markers carcinoembryonic antigen (CEA),
carbohydrate antigen (CA19-9), and alpha-fetoprotein
(AFP) were all within the normal range. A bone marrow
biopsy revealed no abnormalities. A laparoscopic biopsy of
the pancreatic mass (Fig. 3) showed solid pseudopapillary
tumor of the pancreas. Laparoscopy was converted to
laparotomy that showed an encapsulated tumor of ap-
proximately 6 cm in diameter located in the head and the
trunk of her pancreas (Fig. 4). An inspection of her
right kidney showed no tumor. Pancreatoduodenectomy
(Traverso-Longmire) was performed (Fig. 5) with
spleen preservation. Histopathology confirmed com-
pletely resected SPT (Fig. 6). Her postoperative
course was uneventful. There was no adjuvant ther-
apy. Renal scintigraphy and magnetic resonance im-
aging (MRI) after 4 months revealed no metastases.
A follow-up 28 months later showed neither signs of
tumor recurrence nor endocrine and exocrine insuffi-
ciency of the pancreas.
Case 2
A 12-year-old Caucasian girl was admitted to our de-
partment after a mass in her pancreas was incidentally
revealed during USG. CT scans showed a cystic and
solid mass 5.2 × 5.5 × 5.2 cm3 arising from the trunk of
her pancreas (Fig. 7). The tumor was compressing her
superior mesenteric vein and infiltrating her splenic vein
suggesting local invasion. There was no evidence of dis-
tant metastases or abnormalities in laboratory tests.
Laparotomy showed a solid tumor 6 × 6 cm in diameter
Fig. 1 Computed tomography scans showing the presence of the tumor located in the head and the trunk of the pancreas. The tumor measured
4.8 × 4.2 × 5 cm3 (arrows)
Fig. 2 Computed tomography scan showing additional mass. The
mass (approximately 2 cm) was detected in the upper pole of the
right kidney (arrow)
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of the trunk and the tail of her pancreas (Fig. 8), as well
as portal vein thrombosis with collateral circulation. A
complete tumor resection including left pancreatectomy
and splenectomy was performed. Histopathology re-
vealed completely resected Frantz’s tumor (Fig. 9). Her
postoperative course was complicated by necrosis of the
pancreatic head thus Whipple procedure was performed.
Histopathological examination of the pancreatic head
specimen showed necrotic tissue without tumor cells.
Her postoperative course was uneventful. No additional
therapy was administered. MRI of her abdomen 4 months
later revealed no metastases. A follow-up 26 months
later showed no signs of tumor recurrence and no
diabetes. Gastroscopy revealed I0 esophageal varices
treated endoscopically.
Discussion
SPT of the pancreas is extremely rare in children. It is
usually found incidentally on radiologic examination for
other reasons and there are no typical clinical signs and
symptoms. In some patients the tumor is noticed be-
cause of chronic or acute abdominal pain. SPT is usually
localized in the pancreatic head. Exocrine or endocrine
insufficiencies have not yet been described. No specific
tumor markers are known [4–9]. In one of our cases
SPT was discovered incidentally and in the other be-
cause of acute abdominal pain. The localization of the
tumors was head or trunk of the pancreas. In both cases
there were no characteristic biochemical abnormalities,
which is in accordance with reports from other authors.
Awareness of the radiologic features of Frantz’s tumor is
Fig. 3 Laparoscopic biopsy of pancreatic mass
Fig. 4 Encapsulated tumor approximately 6 cm in diameter located
in the head and the trunk of the pancreas
Fig. 5 Specimen of resected pancreatic head with the tumor and
the duodenum
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very important to establish an accurate diagnosis before
operation and planned further surgery. The typical tools
used to diagnose are abdominal USG and CT scan.
SPT appears as a solid well-demarcated mass, usually
heterogenous in echo texture, sometimes containing
hypoechoic fluid-filled cystic areas in USG. CT scans show
a heterogenous mass, often with peripheral contrast en-
hancement corresponding to the fibrous pseudocapsule
[4–10]. In one of our cases the tumor was solid and in the
other it was cystic and solid. Histological evaluation of
SPT shows typically solid and pseudopapillary structures,
intensive vascularization, or hemorrhagic pseudocystic
structures in various proportions [11]. This picture was
also seen in the pathohistological examination in our
patients. Some authors advocate preoperative fine-needle
biopsy (FNB) for distinguishing between benign and ma-
lignant lesions. It can guide surgical management, because
a potentially benign tumor (for example, neuroendocrine,
SPT) may be treated by local excision, in contrast to an
adenocarcinoma, which would require a more extensive
resection [12]. Other authors may not accept this because
of the uncertainty in diagnosis and possible tumor cell
spread. FNB, for instance, may not differentiate between
pancreatoblastoma, the typical pancreatic tumor of young
age, and Frantz’s tumor [9]. We performed a preoperative
biopsy in Case 1 because of a suspected additional mass in
her right kidney, which was not typical for SPT and could
indicate non-Hodgkin lymphoma (NHL). In Case 2 the
characteristic radiological appearance of Frantz’s tumor
was sufficient for qualification for laparotomy and a pre-
ceding biopsy was not necessary. The low grade of malig-
nancy of this tumor, and because the mass is usually
surrounded by a dense fibrous capsule, led to complete re-
section with preservation of as much pancreatic tissue as
possible. Local resection is therefore the therapy of choice.
Distal pancreatectomy with or without splenic preserva-
tion can be performed for tumors in the trunk or tail of
the pancreas, and pancreatoduodenectomy for tumors of
the pancreatic head. Our first patient underwent a pan-
creatoduodenectomy (Traverso-Longmire) because of the
tumor localization in the head and the trunk of her pan-
creas. In our second case, we could perform a left pan-
createctomy because the tumor arose from the trunk and
the tail of her pancreas. Control MRI showed tissue simi-
lar to remnants of the pancreatic tail which might explain
normal levels of glucose. In this patient postoperative
complication made the preservation of the pancreatic
head impossible. Descriptions from case reports concern-
ing incomplete resection of Frantz’s tumor between 1985
and 2008 show that despite the low malignant potential of
SPT, median survival in patients who underwent incom-
plete resection was only 5.7 years. That is why complete
resection of Frantz’s tumor is always justified, even at the
price of difficult mutilating surgery [13]. This is the reason
we should be searching for less radical options with
Fig. 6 Histopathology confirming solid pseudopapillary
tumor (HE×100)
Fig. 7 Computed tomography scans showing a cystic and solid mass 5.2 × 5.5 × 5.2 cm3 arising from the trunk of the pancreas
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complete resection of the tumor as described in literature
central pancreatectomy of a 5 cm tumor located in the
body of pancreas [14]. Up to now there has been no clear
role for chemotherapy or radiotherapy in cases of malig-
nancy, inoperable tumors or relapse. Reported cases and
reviews from the literature where unresectable SPT was
treated with chemotherapy and radiotherapy show bene-
fits in a limited number of patients, such as the report
of a case of a 14-year-old girl with unresectable
Frantz’s tumor with a 7 × 7 cm diameter mass com-
pressing her superior mesenteric vein with acute pan-
creatitis. After two cycles of gemcitabine a repeated CT
scan showed significant interval decrease in the size of
the pancreatic mass 1.5 × 1.0 cm without compression
on her superior mesenteric vein and no evidence of
pancreatitis. She was able to successfully undergo a
pyloric-sparing Whipple procedure [15, 16]. Our two pa-
tients were not considered for preoperative chemotherapy
or radiotherapy. In both cases the tumor was qualified
as radically resectable. At present both patients re-
main without tumor recurrence.
Conclusions
Typical radiological appearance of SPT is an indication
for surgery. The treatment of choice in SPT is tumor re-
section with sparing of pancreatic tissue. We performed
a preoperative biopsy in one of our two cases because of
suspected additional mass in the right kidney. In the
other case, SPT of the trunk and tail of the pancreas as-
sociated with portal vein thrombosis and collateral circu-
lation meant that we could not preserve the pancreatic
head. Control MRI revealed a small piece of tissue char-
acteristic of the pancreatic tail above the upper pole of
the left kidney, which could explain why an insulin
supply was not needed during the postoperative course.
Consent
Written informed consent was obtained from the pa-
tients’ legal guardians for publication of this case report
and any accompanying images. A copy of the written
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